{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:34:11Z","timestamp":1792787651978,"version":"4.5.0"},"reference-count":56,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Institute for In Vitro Sciences, Inc.","id":[{"id":"https:\/\/ror.org\/01aptsm66","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Food and Drug Administration, U.S. Department of Health and Human Services","award":["FAIN 1R13FD007816-01"],"award-info":[{"award-number":["FAIN 1R13FD007816-01"]}],"id":[{"id":"https:\/\/ror.org\/05p26gw61","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Altern Lab Anim"],"abstract":"<jats:p>The Ames bacterial mutagenesis assay (Ames test) has been used for more than 50 years, to help assess the safety of a variety of single chemicals and complex mixtures in the form of solids, liquids or aerosols. Because of the diverse range of substances that need to be tested, many modifications of this test, as well as modifications of the methods by which the test substances are prepared and applied to the bacterial test system, have been developed. Currently, there is a need for mutagenicity testing of both traditional tobacco products and next generation products (NGPs) such as e-cigarettes, heated tobacco products, tobacco-free nicotine products, oral pouches, etc. There are currently no standardised guidelines that cover the differing, often complex, procedures used by different laboratories to assess NGPs with the Ames test. To address this problem, the Institute for In Vitro Sciences (IIVS) convened a workshop, where representatives of industry, government, academia, contract research organisations (CROs) and non-government organisations (NGOs) could present bespoke experimental techniques and data from their testing platforms. The further aim of the workshop was to help formulate some general guidelines that could be used in the testing of tobacco and nicotine products, to allow better comparisons to be made between laboratories. The workshop discussions also resulted in the identification of some suggested areas for future research activities.<\/jats:p>","DOI":"10.1177\/02611929261489755","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:15:08Z","timestamp":1789823708000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Key challenges for\n                    <i>in vitro<\/i>\n                    testing of tobacco and next generation products for regulatory applications: Recommendations for the Ames test"],"prefix":"10.1177","author":[{"given":"Ian","family":"Crooks","sequence":"first","affiliation":[{"name":"BAT (Investments) Limited"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hurtado","sequence":"additional","affiliation":[{"name":"Altria Client Services LLC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Moore","sequence":"additional","affiliation":[{"name":"Martha M Moore LLC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[{"name":"National Center for Toxicological Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Scian","sequence":"additional","affiliation":[{"name":"Toxicology, McKinney Specialty Labs, Richmond, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Leverette","sequence":"additional","affiliation":[{"name":"Scientific and Regulatory Affairs, RAI Services Company, Winston-Salem, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2933-7419","authenticated-orcid":false,"given":"Guy","family":"Lalonde","sequence":"additional","affiliation":[{"name":"Juul Labs, Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Stankowski","sequence":"additional","affiliation":[{"name":"Genetic Toxicology, Charles River Laboratories, Ashland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hollings","sequence":"additional","affiliation":[{"name":"Labcorp"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8756-1562","authenticated-orcid":false,"given":"Katarina","family":"Aleksa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2826-1539","authenticated-orcid":false,"given":"Roman","family":"Wieczorek","sequence":"additional","affiliation":[{"name":"Group Science and Regulatory Affairs, Reemtsma Cigarettenfabriken GmbH, Imperial Brands PLC Company, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Raabe","sequence":"additional","affiliation":[{"name":"Institute for In Vitro Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6947-2589","authenticated-orcid":false,"given":"Rodger","family":"Curren","sequence":"additional","affiliation":[{"name":"Institute for In Vitro Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"e_1_3_6_2_2","unstructured":"ICH. Guideline S2 (R1) on genotoxicity testing and data interpretation for pharmaceuticals intended for human use. https:\/\/www.ema.europa.eu\/en\/ich-s2-r1-genotoxicity-testing-data-interpretation-pharmaceuticals-intended-human-use-scientific-guideline (2012 accessed 13 August 2026)."},{"key":"e_1_3_6_3_2","unstructured":"Committee on Mutagenicity of Chemicals in Food Consumer Products and Food. A strategy for testing of chemicals for genotoxicity. https:\/\/www.gov.uk\/government\/publications\/a-strategy-for-testing-of-chemicals-for-genotoxicity (2011 accessed 13 August 2026)."},{"key":"e_1_3_6_4_2","unstructured":"CORESTA. Rationale and strategy for in vitro toxicity testing of combustible tobacco products. https:\/\/www.coresta.org\/sites\/default\/files\/technical_documents\/main\/IVT-225-CTR_InVitro-Test-Battery_Sept2019.pdf (2019 accessed 13 August 2026)."},{"key":"e_1_3_6_5_2","doi-asserted-by":"crossref","unstructured":"OECD. Test Guideline No. 471: Bacterial Reverse Mutation Test OECD Guidelines for the Testing of Chemicals Section 4. https:\/\/doi.org\/10.1787\/9789264071247-en (2020 accessed 13 August 2026).","DOI":"10.1787\/9789264071247-en"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/5.3.285"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/em.2850190603"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1161(75)90046-1"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1161(83)90010-9"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1161(94)90037-X"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1110(86)90002-3"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1161(76)90077-7"},{"key":"e_1_3_6_13_2","unstructured":"Health Canada. Bacterial reverse mutation assay for mainstream tobacco smoke: T-501. https:\/\/www.canada.ca\/en\/health-canada\/services\/publications\/healthy-living\/tobacco-methods-intake-2017\/t-500\/bacterial-reverse-mutation-assay-mainstream-tobacco-smoke.html (accessed 13 August 2026)."},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.8.4961"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-67202-6_20"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/7.3.175"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1218(84)90132-0"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1218(87)90014-0"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2019.07.004"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/em.22079"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/em.2860060702"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1218(96)90044-0"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.94102s1115"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41021-018-0096-1"},{"key":"e_1_3_6_25_2","author":"van der Leede B","year":"2017","unstructured":"van der Leede B, Schuermans A, Van Gompel J. Are we applying the correct evaluation criteria in the Ames test: An investigation with test results of aromatic amines. UKEMS Annual Conference, 2017.","journal-title":"Are we applying the correct evaluation criteria in the Ames test: An investigation with test results of aromatic amines"},{"key":"e_1_3_6_26_2","volume-title":"Engineering Statistics Handbook Chapter 6: Process or Product Monitoring and Control","author":"NIST\/SEMATECH","year":"2003","unstructured":"NIST\/SEMATECH. Engineering Statistics Handbook Chapter 6: Process or Product Monitoring and Control. https:\/\/www.itl.nist.gov\/div898\/handbook\/pmc\/pmc.htm (2003, accessed 13 August, 2026)."},{"key":"e_1_3_6_27_2","unstructured":"Nordic Committee on Food Analysis. Control charts and control materials in internal quality control in food chemical laboratories. https:\/\/www.nmkl.org\/dokumenter\/prosedyrer\/en\/NMKLProc3_2016Eng.pdf (2016 accessed 13 August 2026)."},{"key":"e_1_3_6_28_2","volume-title":"Internal quality control of data. Chapter 8, Guidelines for quality management in soil and plant laboratories","author":"van Reeuwijk LP","year":"1998","unstructured":"van Reeuwijk LP, Houba VJG. Internal quality control of data. Chapter 8, Guidelines for quality management in soil and plant laboratories. https:\/\/www.fao.org\/docrep\/w7295e\/w7295e0a.htm#8.3\/20control\/20charts (1998, accessed 13 August 2026)."},{"key":"e_1_3_6_29_2","unstructured":"Health Canada. T-115 Determination of \u2018tar\u2019 water nicotine and carbon monoxide in mainstream tobacco smoke. https:\/\/health.canada.ca\/apps\/open-information\/tobacco\/100PDF\/T-115E.PDF (1999 accessed 13 August 2026)."},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1161(93)90157-U"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/geab021"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2018.05.058"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44626-1"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2022.105510"},{"key":"e_1_3_6_35_2","volume-title":"ISO 20778:2018, Cigarettes \u2014 Routine analytical smoking machine \u2014 Definitions and standard conditions with an intense smoking regime","author":"ISO","year":"2018","unstructured":"ISO. ISO 20778:2018, Cigarettes \u2014 Routine analytical smoking machine \u2014 Definitions and standard conditions with an intense smoking regime (1st edition). Geneva: International Organization for Standardization, 2018.","edition":"1"},{"key":"e_1_3_6_36_2","volume-title":"ISO 20768:2018, Vapour products \u2014 analytical vaping machine \u2014 Definitions and standard conditions","author":"ISO","year":"2018","unstructured":"ISO. ISO 20768:2018, Vapour products \u2014 analytical vaping machine \u2014 Definitions and standard conditions (1st edition). Geneva: International Organization for Standardization, 2018.","edition":"1"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/etc.5620130719"},{"key":"e_1_3_6_38_2","volume-title":"ISO 3402:1999, Tobacco and tobacco products \u2014 Atmosphere for conditioning and testing","author":"ISO","year":"1999","unstructured":"ISO. ISO 3402:1999, Tobacco and tobacco products \u2014 Atmosphere for conditioning and testing (4th edition). Geneva: International Organization for Standardization, 1999.","edition":"4"},{"key":"e_1_3_6_39_2","doi-asserted-by":"crossref","unstructured":"OECD. Detailed review paper on the miniaturised versions of the bacterial reverse gene mutation test OECD Series on Testing and Assessment No. 358. https:\/\/doi.org\/10.1787\/919ab767-en (2022 accessed 13 August 2026).","DOI":"10.1787\/919ab767-en"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2016.10.005"},{"key":"e_1_3_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2014.04.017"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2018.01.008"},{"key":"e_1_3_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2019.10.007"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/12.5.927"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2022.06.008"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2024.1452274"},{"key":"e_1_3_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2023.02.005"},{"key":"e_1_3_6_48_2","unstructured":"CORESTA. Vitro Toxicity Testing Sub-Group Technical Report: Ames Assay Inter-Laboratory Proficiency Study 2023. https:\/\/www.coresta.org\/ames-assay-inter-laboratory-proficiency-study-2023-39954.html (2025 accessed 13 August 2026)."},{"key":"e_1_3_6_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1218(95)00078-X"},{"key":"e_1_3_6_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/1752-153X-7-146"},{"key":"e_1_3_6_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2020.104866"},{"key":"e_1_3_6_52_2","doi-asserted-by":"publisher","DOI":"10.1039\/C7TX00109F"},{"key":"e_1_3_6_53_2","doi-asserted-by":"publisher","DOI":"10.1089\/aivt.2022.0001"},{"key":"e_1_3_6_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2019.503081"},{"key":"e_1_3_6_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2012.11.012"},{"key":"e_1_3_6_56_2","unstructured":"ICH. Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk. M7(R1). https:\/\/database.ich.org\/sites\/default\/files\/M7_R1_Guideline.pdf (2017 accessed 13 August 2026)."},{"key":"e_1_3_6_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.3344"}],"container-title":["Alternatives to Laboratory Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02611929261489755","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02611929261489755","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02611929261489755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:17:45Z","timestamp":1790097465000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02611929261489755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":56,"alternative-id":["10.1177\/02611929261489755"],"URL":"https:\/\/doi.org\/10.1177\/02611929261489755","relation":{},"ISSN":["0261-1929","2632-3559"],"issn-type":[{"value":"0261-1929","type":"print"},{"value":"2632-3559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"article-number":"02611929261489755"}}